News

Video

Countdown to CIME 2024: More CME, more innovation, more interaction

Program cochair Arjan Hura, MD, previews this year’s extended schedule with discussions on retina gene therapies, corneal endothelial diseases, and oculoplastics, along with hands-on experiences.

With an expanded program providing attendees with more CME credit and hands-on experience, the 18th Annual Controversies in Modern Eye Care (CIME) meeting will take place at the Hilton Los Angeles/Universal City in California on May 4, 2024.

Arjan Hura, MD, Robert Maloney, MD, and Neda Shamie, MD, from the Maloney-Shamie Vision Institute in Los Angeles are the program cochairs of the meeting. Hura recently spoke with Ophthalmology Times® and Optometry Times® about the conference schedule, which will cover the latest innovations and discussions in cataract and refractive surgery, retina gene therapies, corneal endothelial diseases, and oculoplastics, providing attendees with more CME credits and interactive experiences with industry partners.

To learn more about or to register for the 18th Annual CIME meeting, click here.

Video Transcript

Editor’s note - The following transcript has been lightly edited for clarity.

Arjan Hura, MD:

My name is Arjan Hura, MD. I’m a refractive, cataract, and anterior segment surgeon at the Maloney-Shamie Vision Institute in Los Angeles, California. We are so excited to welcome you back this year to the next iteration of our Controversies in Modern Eye Care symposium taking place on Saturday, May 4, 2024, in Los Angeles.

The history of the meeting has been such that this is a venue where we always discuss what’s new, what’s up and coming in modern eye care, but also, we don’t shy away from the controversies. We embrace different opinions in a healthy and respectful and positive manner.

There’s a lot of new and exciting technology coming on the horizon, not just on the cataract and refractive side of things but there’s a lot of interesting gene therapeutics taking place in retina. There’s some cell therapy being developed for corneal endothelial dystrophies. In the world of oculoplastics and thyroid eye disease, there’s a lot of exciting innovation taking place there as well.

For the first time ever, we’re having this event on a Saturday. We’re expanding the format. So it’s going to be a longer meeting, which means more CME than usual. The industry partners that are coming to this meeting are going to be bringing hands-on, live demo experiences.

Apart from just the benefits of networking, seeing your friends in person, I think there’s going to be a lot of exciting content [and] a lot of hands-on opportunities. We hope that this will be one of the most fulfilling and fun educational events of the year for you.

We can’t wait to see you Saturday, May 4. See you there!

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.